Isoflavonoids for treatment and prevention of alzheimer dementia

Details Isoflavonoids for treatment and prevention of alzheimer dementia Isoflavonoids for treatment and prevention of alzheimer dementia

1996-12-13

1998-03-31

Criares, Theodore J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514457, A61K 3135

Patent

active

057339260

ABSTRACT:
A method of treating or preventing, in a human patient, dementia of Alzheimer type, or age-related loss of cognitive function, said method comprising administering to said patient an isolated isoflavonoid selected from the group consisting of genistein, daidzein, biochanin A, formononetin, O-desmethylangolensin, glycitin, and equol, in an amount sufficient to produce a transient isoflavonoid concentration in the bloodstream of said patient of at least 100 nanomoles/L.

REFERENCES:
patent: 5276054 (1994-01-01), Diez et al.
patent: 5589182 (1996-12-01), Tashiro et al.

Affiliated with

Also associated with

Rating

Isoflavonoids for treatment and prevention of alzheimer dementia does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Isoflavonoids for treatment and prevention of alzheimer dementia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isoflavonoids for treatment and prevention of alzheimer dementia will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-52433